Bnp Paribas Asset Management Holding S.A. Nektar Therapeutics Transaction History

Bnp Paribas Asset Management Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$16.91 - $36.27 $100,648 - $215,879	-5,952 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$31.0 - $36.3 $184,512 - $216,057	5,952 New	5,952 $212,000
Q1 2019 Apr 26, 2019	SELL	$31.58 - $46.35 $320,979 - $471,101	-10,164 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$46.46 - $68.49 $400,810 - $590,863	-8,627 Reduced 45.91%	10,164 $620,000
Q2 2018 Aug 01, 2018	BUY	$46.25 - $104.45 $869,083 - $1.96 Million	18,791 New	18,791 $918,000

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.